Literature DB >> 8898735

Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families.

P Tonin1, B Weber, K Offit, F Couch, T R Rebbeck, S Neuhausen, A K Godwin, M Daly, J Wagner-Costalos, D Berman, G Grana, E Fox, M F Kane, R D Kolodner, M Krainer, D A Haber, J P Struewing, E Warner, B Rosen, C Lerman, B Peshkin, L Norton, O Serova, W D Foulkes, J E Garber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8898735     DOI： 10.1038/nm1196-1179

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  80 in total

1.  Inherited predisposition to pancreatic cancer.

Authors:  E Efthimiou; T Crnogorac-Jurcevic; N R Lemoine; T A Brentnall
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

2.  The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. The BRCA1 Exon 13 Duplication Screening Group.

Authors: 
Journal:  Am J Hum Genet       Date:  2000-05-25       Impact factor: 11.025

3.  BRCA1 and BRCA2 testing: weighing the demand against the benefits.

Authors:  P Devilee
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

4.  Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population.

Authors:  O Lavie; S Narod; F Lejbkowicz; S Dishon; Y Goldberg; O Gemer; G Rennert
Journal:  Ann Oncol       Date:  2010-10-05       Impact factor: 32.976

5.  Ashkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic disease.

Authors:  Sherry I Brandt-Rauf; Victoria H Raveis; Nathan F Drummond; Jill A Conte; Sheila M Rothman
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

6.  Changes in the expression of plasma proteins associated with thrombosis in BRCA1 mutation carriers.

Authors:  Ana Custodio; Antonio J López-Farré; José J Zamorano-León; Petra J Mateos-Cáceres; Carlos Macaya; Trinidad Caldés; Miguel de la Hoya; Elena Olivera; Javier Puente; Eduardo Díaz-Rubio; Pedro Pérez-Segura
Journal:  J Cancer Res Clin Oncol       Date:  2012-02-07       Impact factor: 4.553

7.  Accuracy of BRCA1 and BRCA2 founder mutation analysis in formalin-fixed and paraffin-embedded (FFPE) tissue.

Authors:  M A Adank; E Brogi; F Bogomolniy; E A Wadsworth; K J Lafaro; C J Yee; T Kirchhoff; E J Meijers-Heijboer; N D Kauff; J Boyd; K Offit
Journal:  Fam Cancer       Date:  2006-05-25       Impact factor: 2.375

8.  Low cancer incidence rates in Ohio Amish.

Authors:  Judith A Westman; Amy K Ferketich; Ross M Kauffman; Steven N MacEachern; J R Wilkins; Patricia P Wilcox; Robert T Pilarski; Rebecca Nagy; Stanley Lemeshow; Albert de la Chapelle; Clara D Bloomfield
Journal:  Cancer Causes Control       Date:  2009-09-25       Impact factor: 2.506

9.  Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations.

Authors:  Daniel H Kim; Beth Crawford; John Ziegler; Mary S Beattie
Journal:  Fam Cancer       Date:  2008-10-15       Impact factor: 2.375

10.  Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.

Authors:  P N Tonin; A M Mes-Masson; P A Futreal; K Morgan; M Mahon; W D Foulkes; D E Cole; D Provencher; P Ghadirian; S A Narod
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.